Navigation Links
D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients
Date:5/6/2009

REHOVOT, Israel, May 6 /PRNewswire/ -- D-Pharm announced today that it has submitted IND and Special Protocol Assessment (SPA) packages to the US Food and Drug Administration (FDA), for its pivotal Phase III clinical trial of DP-b99 in acute ischemic stroke patients. D-Pharm plans to initiate the trial later this year following FDA review of the IND and SPA. Recently, D-Pharm also obtained Scientific Advice from the European Medicines Agency (EMEA) on the development strategy for DP-b99 in Europe.

Prior to the IND submission D-Pharm successfully completed the program outlined at the pre-IND meeting held with the FDA in January 2008. The program included additional toxicity studies, a drug interaction study with rtPA, and an interaction study with warfarin in healthy volunteers, as well as scale-up and optimization of the DP-b99 manufacturing process.

The planned Phase III trial is a randomized, double blind, placebo-controlled study (study acronym MACSI: Membrane Activated Chelator Stroke Intervention). It is designed to compare the effect on ischemic stroke outcome between a placebo group and a group of patients treated with 1 mg/kg/day of DP-b99 for 4 consecutive days. D-Pharm plans to enroll 770 moderate to severely affected ischemic stroke patients in over 100 clinical sites in North America, Europe, South Africa and Israel.

"I am especially pleased with this achievement since bringing DP-b99 from design to Phase III really reflects the company's ability to adapt and mature along with our lead product. I look forward to agreement on the SPA and commencing our Phase III trial with DP-b99 under IND" said Alex Kozak, PhD, CEO and President of D-Pharm.

Special Protocol Assessment (SPA) is an instrument of the FDA for evaluating protocols and reaching agreement with sponsors on the design of clinical trials that can be used for drug approval. In our case, it applies to a clinica
'/>"/>

SOURCE D-Pharm Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
2. U.S. Naval Medical Research Center Resubmits IND Application for Proposed RESUS Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
3. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
4. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
5. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
6. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
7. Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
8. U.S. Naval Medical Research Center Resubmits IND Application for Proposed Op RESUS Clinical Trial in Trauma Patients in the Battlefield Setting
9. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
10. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
11. U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...TY, Nov. 27 Booth - 3646...: VAR ), a premier supplier of X-ray tubes and f...s full range of detectors at the RSNA Annual Meeti... 2009. Varian will also be exhibiting X-ray tube ...ialized cancer treatment technologies. ,, Vari...
(Date:11/27/2009)...v. 27 At the upcoming Radiological...arting Sunday, Royal Philips Electronics ( PHG, AE... imaging and informatics solutions designed to dir...providers, by delivering meaningful imaging innova...ce points and easy upgradability. This focus will...
(Date:11/25/2009)...Calif., Nov. 25 Praxis Electronic ...he American Academy of Family Physicians, (AAFP) F...sfaction Survey for improving medical quality, hea...cal for new ARRA Stimulus legislation. Praxis also...a positive effect in determining their salary. Fin...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 1National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 2National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 3National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 4Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 1Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 2Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 3Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 1Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 2Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 3
...CHARLOTTE, N.C., July 9 USHIFU, LLC, a global lea...und (HIFU) technology, is proud,to announce sponso...try,(SIHR), along with co-sponsors Misonix, Inc. (...., (THS). The SIHR is the first and only worldwide...cer treatment using HIFU.,It was established to of...
...SOUTH SAN FRANCISCO, July 9 Cerimon Pharmaceutica...II proof-of-concept study of,Simulect(R) (basilixi...,chronic and potentially sight-threatening inflamm...lacebo-controlled study will evaluate the,safety a...56 patients.,During the study, patients will under...
Other Medicine Technology:Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 2Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 3Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis 2
(Date:11/27/2009)...es may reduce future disease burden, researchers s...-- Encouraging city dwellers to walk and bicycle i...ic health benefits than increased used of low-emis...he study compared the projected health effects in ... for London, England, and Delhi, India: business-...
(Date:11/27/2009)...ngual coloring books designed for children ages 2 ...to educate - inform parents and children alike on ...ars to ABC,S and a host of other topics. , ... 27, 2009 -- Today’s children have enough ga...our of the day, but one of the oldest and simplest...
(Date:11/26/2009)...wswire/ -- The diabetes population in the United S...d annual medical spending on the disease is projec...y, according to a study published in the December ...Diabetes ® Program (NCDP), a program of Novo ...the University of Chicago. ,, According to the ...
(Date:11/26/2009)...l rollercoaster, study finds , , THURSDA...ctor meets the jubilant sports fan. , A new stu...o root for the winning team -- enjoy the greatest ... victory was in doubt, producing feelings of worry...ving weekend as you,re glued to the TV set, watchi...
(Date:11/26/2009)...ons announces a highly effective and unconventiona...to make an economic recovery. , ...he type of challenge that could send ailing holida...vid Benton, business growth expert and author of t...The Rfactor Intensive . “Fear is one of th...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...herapies Will Launch Over Next Decade, According t...LTHAM, Mass., Dec. 2 Decision Resources, one of t... pharmaceutical and healthcare issues, finds that ...o the new special report entitled Cellular Therap...
...ated Psoriasis Patients Will Double by 2017, Accor..., WALTHAM, Mass., Dec. 2 Decision Resources, on...ms for pharmaceutical and healthcare issues, finds...t to more than double to nearly $5 billion over th...
...Inc. (NYSE: MYL ) today,announced that it and it...ered,into a settlement agreement with Novartis Pha...ternational AG related to Letrozole Tablets, the g...ement, which demonstrates our ability to once,agai...
...ec. 2 TYRX, Inc., a leader in the development and...cts, today announced the appointment of David Elli...r commercial operations. , , Mr. Elliot bring...ser-based antimicrobial and vascular plaque destru...
...orm an integral part of most of,original equipment... become,essential for service providers in the Eur...mpetitive and constantly improve their services an...http://www.medicalimaging.frost.com ),European Med...
... Xena Health and Solutions Medical Billing Team Up...aims in a Cloud" as a SaaS Application. , ...ecember 2, 2008 -- Making medical insurance claims... Modelling partners Xena Health and Solutions Medi...
Other Medicine News:Health News:Market for Cellular Therapies Will Grow at a Robust Annual Rate of More Than 30 Percent in the United States Through 2017 2Health News:Biologic Drugs, Particularly Centocor/Janssen-Cilag's Stelara and Abbott/Eisai's Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017 2Health News:Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:Corporate Modelling Partners Start Selling BPM in Cloud Service 2
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: